Responsive image

Common name

N,N-dimethylmethanamine

IUPAC name

N,N-dimethylmethanamine

SMILES

N(C)(C)C

Common name

N,N-dimethylmethanamine

IUPAC name

N,N-dimethylmethanamine

SMILES

N(C)(C)C

INCHI

InChI=1S/C3H9N/c1-4(2)3/h1-3H3

FORMULA

C3H9N

Responsive image

Common name

N,N-dimethylmethanamine

IUPAC name

N,N-dimethylmethanamine





Molecular weight

59.110

clogP

-0.577

clogS

-0.200

Frequency

0.0371





HBond Acceptor

1

HBond Donor

0

Total Polar
Surface Area

3.24

Number of Rings

0

Rotatable Bond

0

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00574 Ibandronate Responsive image Bone Density Conservation Agents; Antihypocalcemic Agents; Antiresorptives; Bisphosphonates; Musculo-Skeletal System; Drugs Affecting Bone Structure and Mineralization; Drugs for Treatment of Bone Diseases; For the treatment and prevention of osteoporosis in postmenopausal women.
FDBD00590 Trimipramine Responsive image Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Adrenergic alpha-1 Receptor Antagonists; Antidepressive Agents; Nervous System; Antidepressants; Psychoanaleptics; Non-Selective Monoamine Reuptake Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; For the treatment of depression and depression accompanied by anxiety, agitation or sleep disturbance.
FDBD00599 Naftifine Responsive image Antifungal Agents; Dermatologicals; Antifungals for Topical Use; Antifungals for Dermatological Use; For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms .
FDBD00612 Carbinoxamine Responsive image Histamine H1 Antagonists; Histamine Antagonists; Respiratory System; Aminoalkyl Ethers; Antihistamines for Systemic Use; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis, as well as allergic conjunctivitis caused by foods and inhaled allergens. Also for the relief of allergic reactions to blood or plasma, and the symptomatic management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema.
FDBD00631 Olopatadine Responsive image Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Histamine Antagonists; Respiratory System; Ophthalmologicals; Sensory Organs; Nasal Preparations; Decongestants and Antiallergics; Antiallergic Agents, Excl. Corticosteroids; CYP3A4 Inhibitors; For the treatment of ocular itching associated with allergic conjunctivitis.
FDBD00654 Tripelennamine Responsive image Anti-Allergic Agents; Histamine H1 Antagonists; Histamine Antagonists; Respiratory System; Dermatologicals; Antipruritics, Incl. Antihistamines, Anesthetics, Etc.; Antihistamines for Topical Use; Antihistamines for Systemic Use; Substituted Ethylene Diamines; CYP2D6 Inducers; CYP2D6 Inducers (strong); Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.
FDBD00697 Brompheniramine Responsive image Anti-Allergic Agents; Histamine H1 Antagonists; Respiratory System; Antihistamines for Systemic Use; Substituted Alkylamines; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; For the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing.
FDBD00717 Terbinafine Responsive image Antifungal Agents; Dermatologicals; Antifungals for Topical Use; Antifungals for Dermatological Use; Antifungals for Systemic Use; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; For the treatment of dermatophyte infections of the toenail or fingernail caused by susceptible fungi. Also for the treatment of tinea capitis (scalp ringworm) and tinea corporis (body ringworm) or tinea cruris (jock itch).
FDBD00723 Ranitidine Responsive image Anti-Ulcer Agents; Alimentary Tract and Metabolism; Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord); Drugs for Acid Related Disorders; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; H2 Antagonists; Combined Inhibitors of CYP3A4 and P-glycoprotein; Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).
FDBD00747 Mechlorethamine Responsive image Antineoplastic Agents; Immunosuppressive Agents; Antineoplastic Agents, Alkylating; Alkylating Agents; Chemical Warfare Agents; Irritants; Antineoplastic and Immunomodulating Agents; Nitrogen Mustard Analogues; For the palliative treatment of Hodgkin's disease (Stages III and IV), lymphosarcoma, chronic myelocytic or chronic lymphocytic leukemia, polycythemia vera, mycosis fungoides, and bronchogenic carcinoma. Also for the palliative treatment of metastatic carcinoma resulting in effusion.
108 , 11
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2reg_ligand_1_1.mol2 2reg 1 -5.84 C[N+](C)(C)C 5
2rin_ligand_1_0.mol2 2rin 1 -5.74 C[N+](C)(C)C 5
4bgk_ligand_1_3.mol2 4bgk 1 -5.64 [N+](C)(C)(C)C 5
4c5w_ligand_1_0.mol2 4c5w 1 -5.64 C[N+](C)(C)C 5
1sw2_ligand_frag_0.mol2 1sw2 1 -5.63 [NH+](C)(C)C 4
892 , 90